SSPC, Taighde Éireann – Research Ireland Centre for Pharmaceuticals

SSPC, an Ionad Taighde Éireann do Chógaisíocht

 

SSPC is a world-leading hub of Irish research expertise developing innovative technologies to address key challenges facing the pharmaceutical and biopharmaceutical industry. Our in-depth scientific and engineering research expertise aids companies who need tailored solutions to their bespoke challenges.

Discover Our Impacts - Faigh amach faoinár dtionchair

SSPC provides the life sciences sector with a nationally distributed, research performing community that enables high impact, collaborative research between industry and academic partners.

SSPC is committed to translating its excellent science into impact through five societal goals: Sustainability, Small Molecule, Biologics, Health, Education and Public Engagement.

Sustainability

Small Molecule

Biologics

Health

Education & Public Engagement

Talent

SSPC nurtures a talent pipeline of high calibre scientists and engineers for the sector, through our internal PhD training programme and various CPD mechanisms available to our industry partners. SSPC offers a unique proposition through its industry placement programme and 63% of SSPC graduates go on to be employed in industry both nationally and globally.

Industry

Since its inception, SSPC has successfully collaborated with over 50 industry partners, composed of indigenous and foreign operations, whose size range from small to multi-national. Collectively, this demonstrates a strong track-record in delivering applied research that enables industry to solve challenges leading to the development of better medicine. SSPC has supported 54 industry projects since 2019.

Researchers

Economic Impact since 2013

Industry Partners

Jobs created in industry following FDI

Peer-Reviewed Publications

International Co-Authors in 48 countries across 6 continents

%

Transition of Researchers to Industry

Education & Public Engagement Activities

Latest News

SSPC welcomes new investigator Dr Katie Ryan

SSPC welcomes new investigator Dr Katie Ryan

Dr Katie Ryan, University College Cork (UCC) SSPC welcomes new investigator, Dr Katie Ryan (UCC), who will be investigating the impact of novel processing techniques on the stability and functionality of oligonucleotides in order to expand the repertoire of techniques...

read more
SSPC supporting cleaner greener pharmaceutical manufacturing

SSPC supporting cleaner greener pharmaceutical manufacturing

SSPC invites you to hear from some of our researchers who are supporting advances to Cleaner Greener Pharmaceutical Manufacturing on Friday, March, 26th from 12-3pm. Register here for more details on the event and our impressive line-up of speakers. The European Green...

read more
SSPC welcomes new investigator Dr Jessica Whelan

SSPC welcomes new investigator Dr Jessica Whelan

Dr Jessica Whelan, University College Dublin (UCD) SSPC welcomes new investigator, Assoc. Prof. Jessica Whelan at UCD, who will be working on the study of cryopreservation of mammalian cells. It is cutting edge research with high impact that will provide not just...

read more

SSPC Years in Review, and News Updates

View or download our latest news and research outputs.

SSPC’s world-leading Research Programme

Our unique and innovative culture of collaboration is helping the global pharmaceutical and biopharmaceutical industry to develop more environmentally sustainable methods for drug manufacturing; to increase the range of medicines available to the public and to reduce drug manufacturing costs. SSPC’s advanced research programme extends from Molecule, Materials and Medicine into the Manufacturing and Modelling space.

These themes focus on developing new methodologies for the asymmetric synthesis of APIs, molecules & methods for automated & in-flow generation of targeted drug hybrids & new therapeutic agents.

Advancing the understanding of single-component crystalline materials (SCCMs) and, especially, multi-component crystalline materials (MCCMs) in order to enable improved orally delivered drug products.

Optimising the development, production & use of safe, effective medicines with focus on poorly soluble drugs, personalized, age appropriate medicines & rational formulation approaches with predictive performance.

Enabling a disruptive change in manufacture of drug substances & drug products, through the development & implementation of continuous manufacturing, flow chemistry & end-to-end manufacturing methodologies.

This theme will develop new techniques to design and predict behaviour in silico in order to reduce trial-and-error experimentation. Developing new transformative physical models for broad uptake in drug manufacture.